Physician profile
Scott Wang
NPI 1124297155
$3,514.88
in general payments reported to CMS, 2019-2025
35 companies · $1,160 in 2025
The $1,160 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $110 · 2021: $29.88 · 2022: $159 · 2023: $641 · 2024: $926 · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,726.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $547.25 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $525.66 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $336.30 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $317.33 | 2023-2025 | Mounjaro, Zepbound, Emgality |
| Abbott Laboratories | $239.48 | 2019-2025 | Freestyle Libre 3, Eterna, Proclaim |
| Pfizer INC. | $226.84 | 2019-2025 | |
| Exact Sciences Corporation | $181.70 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $132.00 | 2019-2025 | Krystexxa, Repatha, Evenity |
| Dexcom, INC. | $119.12 | 2024-2025 | Dexcom G6 Transmitter |
| Itamar Medical INC | $100.21 | 2022-2023 | Watchpatone |
| Janssen Pharmaceuticals, INC | $96.52 | 2019-2025 | Spravato |
| Idorsia Pharmaceuticals US INC | $69.48 | 2022-2024 | Quviviq |
| Dynavax Technologies Corporation | $57.89 | 2023-2025 | Heplisav-B |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.80 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $43.71 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $41.63 | 2019-2020 | |
| Abbvie INC. | $39.76 | 2023-2024 | Ubrelvy |
| Bayer Healthcare Pharmaceuticals INC. | $35.79 | 2023-2025 | |
| Astellas Pharma US INC | $31.16 | 2025 | Veozah |
| Alnylam Pharmaceuticals INC. | $27.10 | 2025 | Givlaari |
| Inari Medical, INC. | $27.01 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Madrigal Pharmaceuticals | $23.41 | 2025 | Rezdiffra |
| Philips North America LLC | $22.65 | 2024 | (Ck7) Extended Holter |
| Seqirus USA INC | $22.06 | 2024 | Fluad, Flucelvax |
| Amarin Pharma, INC. | $20.13 | 2019 | |
| Renalytix Ai, INC. | $19.99 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Inspire Medical Systems, INC. | $19.69 | 2025 | Inspire |
| Gilead Sciences, INC. | $19.50 | 2025 | |
| Esperion Therapeutics, INC. | $19.33 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.94 | 2020 | |
| Edwards Lifesciences Corporation | $17.99 | 2024 | Sapien 3 Ultra Resilia |
| Axsome Therapeutics, INC. | $17.61 | 2025 | Auvelity |
| Acerus Pharmaceuticals Corporation | $14.79 | 2022 | |
| Kyowa Kirin, INC. | $14.75 | 2025 | |
| Medtronic, INC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.